GlassScriptPhysician profile
Mohamed Zakkar
NPI 1285646828
$1,580.13
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $875 · 2020: $270 · 2021: $170 · 2022: $194 · 2023: $57.32 · 2024: $14.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $71.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $71.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $418.60 | 2019-2023 | Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $318.37 | 2019-2022 | |
| Genentech USA, INC. | $194.49 | 2019-2020 | |
| Genzyme Corporation | $122.10 | 2022 | |
| Grifols USA, LLC | $111.63 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $85.48 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $44.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $43.73 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $40.48 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $30.02 | 2023 | Acthar |
| Advanced Respiratory, INC | $25.63 | 2019 | |
| Mylan Specialty L.P. | $24.87 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $20.69 | 2019 | |
| Philips North America LLC | $19.54 | 2021 | |
| Circassia INC. | $17.81 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.30 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.94 | 2020 | |
| Amgen INC. | $14.41 | 2024 | Tezspire |
| Merck Sharp & Dohme LLC | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohamed Zakkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.